Johnson & Johnson (JNJ) FY2012 results: revenue $67.2 billion, up 3.4% on the year
Johnson & Johnson (JNJ) reported revenue of $67.2 billion for fiscal 2012, the year ended 30 December 2012, up 3.4% on the year before. Net income was $10.9 billion, up 12.2%, and diluted earnings per share $3.86. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2013.
Revenue
$67.2 billion
+3.4% on the year
FY2007FY2012
Operating margin
22.2%
21.2% a year earlier
FY2007FY2012
Net income
$10.9 billion
+12.2% on the year
FY2007FY2012
Diluted EPS
$3.86
+10.6% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
67,224
65,030
61,587
+3.4%
Cost of revenue
21,658
20,360
18,792
+6.4%
Gross profit
45,566
44,670
42,795
+2.0%
Gross margin
67.8%
68.7%
69.5%
Research and development
7,665
7,548
6,844
+1.6%
Selling, general and administrative
20,869
20,969
19,424
-0.5%
Operating income
14,955
13,765
17,700
+8.6%
Operating margin
22.2%
21.2%
28.7%
Interest expense
532
571
455
-6.8%
Pre-tax income
13,775
12,361
16,947
+11.4%
Income tax
3,261
2,689
3,613
+21.3%
Effective tax rate
23.7%
21.8%
21.3%
Net income
10,853
9,672
13,334
+12.2%
Net margin
16.1%
14.9%
21.7%
Diluted EPS
$3.86
$3.49
$4.78
+10.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
15,396
14,298
16,385
+7.7%
Capital expenditure
2,934
2,893
2,384
+1.4%
Free cash flow
12,462
11,405
14,001
+9.3%
Free cash flow margin
18.5%
17.5%
22.7%
Cash from investing
-4,510
-4,612
-7,854
Cash from financing
-20,562
-4,452
-4,980
Depreciation and amortisation
3,666
3,158
2,939
+16.1%
Share-based compensation
662
621
614
+6.6%
Buybacks
12,919
2,525
2,797
+411.6%
Dividends paid
6,614
6,156
5,804
+7.4%
Dividend per share
$2.40
$2.25
$2.11
+6.7%
Diluted shares, weighted
2,813m
2,775m
2,789m
+1.3%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
64,826
57,080
56,579
+13.6%
Debt
16,165
19,627
16,773
-17.6%
Other liabilities
40,356
36,937
29,556
+9.3%
Total liabilities and equity
121,347
113,644
102,908
+6.8%
Fixed assets
16,097
14,739
14,553
+9.2%
Goodwill
22,424
16,138
15,294
+39.0%
Intangible assets
28,752
18,138
16,716
+58.5%
Investments
6,178
7,719
8,303
-20.0%
Cash and equivalents
14,911
24,542
19,355
-39.2%
Receivables
11,309
10,581
9,774
+6.9%
Inventory
7,495
6,285
5,378
+19.3%
Other assets
14,181
15,502
13,535
-8.5%
Total assets
121,347
113,644
102,908
+6.8%
10-K for the year ended 30 December 2012, filed 22 February 2013: the filing.